d-serine
Showing 1 - 25 of 6,554
MDD Trial in Basel (D-serine, Placebo)
Recruiting
- Major Depressive Disorder
- D-serine
- Placebo
-
Basel, Baselstadt, SwitzerlandUniversity of Basel, Department of Psychiatry (UPK)
Oct 31, 2022
Schizophrenia, Schizo Affective Disorder Trial in New York (D-serine, Placebo)
Not yet recruiting
- Schizophrenia
- Schizo Affective Disorder
- D-serine
- Placebo
-
New York, New YorkNew York State Psychiatric
Jul 25, 2022
Psychotic Disorder Trial in Basel (D-serine, Placebo)
Recruiting
- Psychotic Disorder
- D-serine
- Placebo
-
Basel, Basel-Stadt, SwitzerlandUPK Basel
Jan 21, 2022
Schizophrenia Trial in Orangeburg (D-serine)
Completed
- Schizophrenia
- D-serine
-
Orangeburg, New YorkNathan Kline Institute
Sep 14, 2020
Postoperative Cognitive Dysfunction Trial (Blood sampling for assessment of the level of D-Amino Acid Oxidase, D-serine and
Unknown status
- Postoperative Cognitive Dysfunction
- Blood sampling for assessment of the level of D-Amino Acid Oxidase, D-serine and Serine in blood
- +2 more
- (no location specified)
Dec 21, 2020
Rosacea Trial in San Diego (Ivermectin)
Completed
- Rosacea
-
San Diego, CaliforniaUCSD Division of Dermatology
Oct 1, 2021
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,
Completed
- Metastatic Melanoma
- +3 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston
Active, not recruiting
- Metastatic Melanoma
- +2 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Completed
- Stage III Cutaneous Melanoma AJCC v7
- +5 more
- Aldesleukin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
-
Los Angeles, California
- +3 more
Nov 16, 2022
COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)
Active, not recruiting
- COL6A3 Positive
- +3 more
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston
Active, not recruiting
- HLA-A*0201 Positive Cells Present
- +3 more
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Triple Negative Breast Cancer
- Aldesleukin
- +12 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 9, 2023
Hereditary Sensory Neuropathy Type I Trial in London (L-serine, Placebo)
Recruiting
- Hereditary Sensory Neuropathy Type I
- L-serine
- Placebo
-
London, United KingdomUniversity College London
Oct 31, 2023
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Healthy Volunteers Trial in Adelaide (CTP-692, D-Serine)
Completed
- Healthy Volunteers
- CTP-692
- D-Serine
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Mar 14, 2019
Crohn Disease Trial in Ann Arbor (Low serine diet, High serine diet)
Recruiting
- Crohn Disease
- Low serine diet
- High serine diet
-
Ann Arbor, MichiganUniversity of Michigan
May 19, 2022
Amyotrophic Lateral Sclerosis (ALS) Trial in Lebanon (L-Serine)
Recruiting
- Amyotrophic Lateral Sclerosis (ALS)
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Feb 22, 2022
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Houston (biological,
Recruiting
- Metastatic Melanoma
- +5 more
- Aldesleukin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 10, 2020
Liposarcoma, Atypical Lipomatous Tumor Trial in Montpellier (Blood sampling)
Recruiting
- Liposarcoma
- Atypical Lipomatous Tumor
- Blood sampling
-
Montpellier, FranceInstitut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022